Immune analysis demonstrated enhanced tumor infiltration of CD4+ and CD8+ T cells, initiated by TILT-123 and amplified by TIL infusion, while modulation of peripheral blood NK cell phenotypes further strengthened the immune response. The gene discussed is CD4; the disease is neoplasm.